Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

09/12/2014 ADAM involved in the project of shared DC between Malaysia and Catalonia 02/12/2014 ESADE, 4th best business school in Europe 25/11/2014 Nanoparticle technology triples the production of biogas 13/11/2014 A little piece of SENER on comet 67P 05/11/2014 New catalysts investigated with the ALBA Synchrotron 04/11/2014 SENER hosts a meeting with ESA, NASA and ROSKOSMOS in its offices in BSP
36 37 38 39 40 41 42 43 44 45 46